About Santanu Roy

Having been fascinated by the traditional and evolving factors that affect investment decisions, Santanu decided to pursue a career as an investment analyst. Prior to his switch to investment research, he was a process associate at Cognizant.

With a master's degree in business administration and a fundamental approach to analyzing businesses, he aims to help retail investors identify the best long-term investment opportunities.


Recent Articles By Santanu Roy

: JNJ |  News, Ratings, and Charts

1 Stable Stock to Put on Your Buy List Now

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on…
: PNRG |  News, Ratings, and Charts

3 Energy Stocks That Are Screaming Buys Right Now

Despite the recent retreat in oil and gas prices from their peaks, analysts expect energy prices to rise, driven by substantial demand and restricted supply. A surge in demand due to the reopening of China’s economy could significantly boost oil and gas prices. Given the industry tailwinds, we think it could be opportune to invest in fundamentally sound energy stocks PrimeEnergy Resources (PNRG), Epsilon Energy (EPSN), and Adams Resources (AE). Read on…
: YELP |  News, Ratings, and Charts

1 Small-Cap Stock to Buy for 2023 and Beyond

While the consistent and improving business performance and capital discipline of Yelp (YELP) are yet to be adequately reflected in its price, it presents an attractive opportunity for bargain hunters in 2023 and beyond. Read on…
: ADT |  News, Ratings, and Charts

1 Security Stock That's Well Positioned for 2023

Since its partnership with State Farm, ADT Inc. (ADT), headquartered in Boca Raton, Florida, seems to have switched gears. We look at the factors that promise to make this turnaround, characterized not in the least by its return to profitability, enduring even in the treacherous macroeconomic terrain of 2023. Read on…
: CVS |  News, Ratings, and Charts

3 Stocks with Major Upside Potential

With recent red flags making investors jittery about a not-so-soft landing courtesy of an over-cautious Fed, loading up on fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Ooma (OOMA) could set investors up for market-beating risk-adjusted returns. Continue reading…
: FUBO |  News, Ratings, and Charts

1 Popular Stock to Think Twice About Before Buying

A recent uptick in the volume of FUBO stock echoes its increasing revenues and subscribers. A look into the fundamentals of the business made us question whether optimism is justified. Read on…
: MOMO |  News, Ratings, and Charts

1 China Stock to Add to Your Watchlist in 2023

After a prolonged and self-imposed economic and demographic slumber, a Chinese reawakening is expected to put wind in the sails of Hello Group (MOMO), whose fundamentals make it worthy of investment in 2023. Read on…
: GLD |  News, Ratings, and Charts

3 Precious Metals ETFs to Buy for 2023

The stock market is yet to see an end to the Fed’s monetary tightening to control inflation. On top of that, recent economic data reflecting an economic and demographic decline in China is a stark reminder that the global economy, battered by various headwinds, may spiral into a full-blown recession. Hence, SPDR Gold Trust ETF (GLD), iShares Silver Trust ETF (SLV), and Aberdeen Standard Physical Platinum Shares ETF (PPLT) could be ideal hedges against persistent market volatility. Continue reading…
: ABBV |  News, Ratings, and Charts

The #1 Pharma Stock to Buy in January 2023

While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on…
: LLY |  News, Ratings, and Charts

The 3 Best Retirement Stocks to Buy for Investors Over 55

While moderation of the inflation rate is December has triggered a bear market rally, the stock market is unlikely to stabilize in the near term because of the likelihood of further interest rate hikes. Hence, shares of fundamentally strong and growing businesses with a track record of increasing dividend payouts, such as Eli Lily (LLY), Merck (MRK), and Archer-Daniels-Midland Company (ADM), could be considered by investors aged 55 and above for steady income generation. Continue reading…
Page generated in 1.2631 seconds.